The HIV prevention shot, lenacapavir, will be rolled out at South African clinics within the next couple of months and from 2027, the health department will also buy generics. But how best to spend the HIV prevention budget so that the country can drive infections down as fast as possible? We take a look at what the modelling data shows
South Africa has been given a narrow window to turn the ship around. Whether this Budget becomes a footnote or a foundation depends on what happens next — in Cabinet, in the SOEs, in municipalities and in the daily grind of governance
Who should get what slice of the pie once the medicine is available in public clinics? And are numbers alone what would drive decisions?
None of the companies that will be involved have a licence from the inventor of Lenacapavir, Gilead Sciences, to make the jab
From discontinued insulin pens to overpriced TB drugs, meet the young South African holding drug makers to account on behalf of patients
The country’s medicines regulator Sahpra says it’s on track to announce its registration decision by the end of October
The Botswana Network on Ethics, Law and HIV/Aids says the crisis is not an isolated supply-chain issue but a ‘systemic failure’ that demands urgent government intervention
According to a survey, 85% of managers reported that their clinics faced staffing shortages, though only one in five blamed these on the US President’s Emergency Plan For Aids Relief cuts
The shot, called Lenacapavir, has a 100% success rate in preventing young women from getting HIV through sex
Hetero and Dr Reddy’s will be funded by the Gates Foundation and Unitaid to produce and sell the twice-a-year anti-HIV shot around R692 per person a year
HIV prevention services have been heavily affected by the pause on the US President’s Emergency Plan for Aids in the country, with remote mobile clinics that served hard-to-reach people now closed
The least the Trump administration could have done was provide ample warning that it was going to cut aid
Although the NHI offers much-needed reform, it must find a new way to care for patients – an approach that treats people emotionally, physically, socially, psychologically and spiritually
An inter-referral system between conventional and complementary medical practitioners is essential to giving patients optimal care in our diverse society
Aid dependency in the fight against HIV/Aids is not sustainable; Africa must own its health future. With political will, nothing is impossible
Donald Trump’s funding freeze underlines that South Africa needs to prioritise the development of its pharmaceutical manufacturing sector
The United States’ shutdown of HIV/Aids funding may harm global Aids programmes irreparably, jeopardising millions of lives and putting HIV prevention at risk
The recent termination of USAid to HIV/Aids and TB organisations in South Africa was a bone of contention in the 2025 budget
In a changing world order, the continent must make urgent moves to wean itself off handouts
The US president’s cutting of financial support has cut life-saving treatment for many in SA